Broker Regulation

Drug companies and hospitals are gearing up for a big battle on Capitol Hill over the future of the 340B Drug Pricing Program.

An arm of the U.S. Department of Health and Human Services (HHS) may have started a major new fight between patient privacy advocates and substance abuse benefits managers with updated regulations on how patient information can be shared.

Pharma claims to like the free market, but in the year ahead, Gottlieb is set to prove how the free market can cut both ways for drugmakers.

Although the employer mandate under the Affordable Care Act isnt new, this is the first year that the IRS is attempting to collect penalties from companies that didnt shell outfor violations incurred in 2015.

A U.S. District judge has issued a preliminary injunction barring the Trump administrations rule changes allowing some employers to opt out of providing contraceptive coverage under the Affordable Care Act.

The Centers for Medicare and Medicaid Services has given U.S. health insurers bad news and good news about how individual health coverage performed in 2016.